AD
Andrew D Dickinson (Chief Financial Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $469K of GILD (3,000 sh × $156.22, as filed), executed Oct 15. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.1M
shares × price, as filed
Last traded
Oct 15
Filed Oct 16
Median ADV $1.0B across their filed names
Open performance→Volume by month
Buys $0
Sells $61.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
11 filings
Sector per market data · by filing · past 12 months
Most traded names
GILDRecent filings
GILDSALE
Gilead Sciences, Inc.
View filing →
$250K2,500 sh × $99.82
Exec May 15 2025
Filed May 16 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $266K
2,500 sh × $106.40
Exec Apr 15 2025
Filed Apr 16 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $276K
2,500 sh × $110.53
Exec Mar 17 2025
Filed Mar 18 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $2.1M
17,929 sh across 2 lots
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $260K
2,500 sh × $104.09
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $14.1M
137,676 sh × $102.22
Exec Feb 12 2025
Filed Feb 13 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $13.8M
142,180 sh × $97.22
Exec Jan 31 2025
Filed Feb 3 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $228K
2,500 sh × $91.35
Exec Jan 15 2025
Filed Jan 16 2025 · 5:30 PM ET More filings →